Express Scripts: Is EpiPen Reaction Overblown?
August 26, 2016 at 13:14 PM EDT
Yesterday, Express Scripts ( ESRX ) got beaten down after it and other pharmacy benefits managers like CVS Health ( CVS ) were blamed by Mylan ( MYL ) for the rise in EpiPen prices . Jefferies analyst Brian Tanquilut and team explain why they think the reaction was overblown:
